Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Noorda

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 6, 2001
Adult height and age at menarche in childhood cancer survivorsE M Noorda, R Somers, F E van Leeuwen, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 16, 2003
[Regional isolated perfusion: also applicable in elderly patients]E M Noorda, B C Vrouenraets, O E Nieweg, et al.
Journal of Surgical Oncology|November 27, 2002
Isolated limb perfusion with melphalan for femoral metastases of breast cancer: case reportE M Noorda, B C Vrouenraets, O E Nieweg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 4, 2022
Long-term quality of life and aesthetic outcomes after breast conserving surgery in patients with breast cancerM Zwakman, A Tan, C Boersma, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 18, 2006
Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusionE M Noorda, B C Vrouenraets, O E Nieweg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 20, 2003
Prognostic factors for survival after isolated limb perfusion for malignant melanomaE M Noorda, B C Vrouenraets, O E Nieweg, et al.
Annals of Surgical Oncology|December 5, 2002
Safety and efficacy of isolated limb perfusion in elderly melanoma patientsE M Noorda, B C Vrouenraets, O E Nieweg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 16, 2007
The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusionE M Noorda, R H J van Kreij, B C Vrouenraets, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 12, 2005
Major amputation for intractable extremity melanoma after failure of isolated limb perfusionM R Kapma, B C Vrouenraets, O E Nieweg, et al.
Journal of Surgical Oncology|July 20, 2005
Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patientsR B Takkenberg, B C Vrouenraets, A N van Geel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|April 6, 2001
Adult height and age at menarche in childhood cancer survivorsE M Noorda, R Somers, F E van Leeuwen, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 16, 2003
[Regional isolated perfusion: also applicable in elderly patients]E M Noorda, B C Vrouenraets, O E Nieweg, et al.
Journal of Surgical Oncology|November 27, 2002
Isolated limb perfusion with melphalan for femoral metastases of breast cancer: case reportE M Noorda, B C Vrouenraets, O E Nieweg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 4, 2022
Long-term quality of life and aesthetic outcomes after breast conserving surgery in patients with breast cancerM Zwakman, A Tan, C Boersma, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 18, 2006
Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusionE M Noorda, B C Vrouenraets, O E Nieweg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 20, 2003
Prognostic factors for survival after isolated limb perfusion for malignant melanomaE M Noorda, B C Vrouenraets, O E Nieweg, et al.
Annals of Surgical Oncology|December 5, 2002
Safety and efficacy of isolated limb perfusion in elderly melanoma patientsE M Noorda, B C Vrouenraets, O E Nieweg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 16, 2007
The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusionE M Noorda, R H J van Kreij, B C Vrouenraets, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 12, 2005
Major amputation for intractable extremity melanoma after failure of isolated limb perfusionM R Kapma, B C Vrouenraets, O E Nieweg, et al.
Journal of Surgical Oncology|July 20, 2005
Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patientsR B Takkenberg, B C Vrouenraets, A N van Geel, et al.
Pageof 2